#CCR22 – Estudo randomizado | Vitamina C intravenosa aumenta o risco de morte ou disfunção persistente de órgão em adultos com sepse em UTI.
19 Jun, 2022 | 17:03hConteúdos relacionados:
Comentário no Twitter
In this trial of IV vitamin C in adult patients with sepsis, those who received a vitamin C infusion had a higher risk of death or persistent organ dysfunction at 28 days than those who received placebo. #CCR22 https://t.co/8tpW7Yud6a pic.twitter.com/1Jf9aIka8Y
— NEJM (@NEJM) June 15, 2022


